This HTML5 document contains 48 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q84114038
rdf:type
wikibase:Item
schema:description
article scientifique publié en 2012 wetenschappelijk artikel artículu científicu espublizáu en mayu de 2012 наукова стаття, опублікована в травні 2012 scientific article published on 09 May 2012
p:P577
wds:Q84114038-473BFF36-18E6-413C-8DED-FE749661997D
wdt:P577
2012-05-09T00:00:00Z
p:P2093
wds:Q84114038-D75B7606-BFCE-4464-B107-29BD0C005578 wds:Q84114038-AFE1C501-BB6E-4FB0-842E-8AE4069C3D49 wds:Q84114038-53726818-0045-4312-A782-30A3A77172CA wds:Q84114038-413B5F41-2ABB-41C9-BF09-9B6F834E4F65 wds:Q84114038-251CEF6F-060A-42B9-99EA-44E8078014FF wds:Q84114038-0CC10C09-DC55-48A0-91CD-893884DC2863
wdt:P2093
Hunter Gillies Marcus Littman David Pizzuti Andrea Brown Tobias Peschel Noreen Henig
rdfs:label
Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension
skos:prefLabel
Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension
schema:name
Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension
p:P50
wds:Q84114038-B14E79C8-54D9-4205-B1FF-90ECB2952438
wdt:P50
wd:Q93152543
p:P1476
wds:Q84114038-97C05FAC-8E88-4EED-B2D7-75CCCF5444AF
wdt:P1476
Long-term hepatic safety of ambrisentan in patients with pulmonary arterial hypertension
p:P304
wds:Q84114038-2534CE3D-ACC5-49B9-B649-11DBF16F0711
wdt:P304
80-81
p:P31
wds:Q84114038-A6B28C90-420B-4D38-8DC9-5DC798400213
wdt:P31
wd:Q13442814
p:P921
wds:Q84114038-E88FDCFB-E26C-4D6C-85BA-C13E85D90B07
wdt:P921
wd:Q41861
p:P698
wds:Q84114038-3B84ABC6-BB27-4616-8E75-48C271D9856C
wdtn:P698
n9:22578922
wdt:P698
22578922
p:P1433
wds:Q84114038-A89B2C69-5109-4A65-BC30-D7CD9669C64A
wdt:P1433
wd:Q2984355
p:P433
wds:Q84114038-0469B5FF-FA4F-4A7B-ACF1-7D4FC22C39D2
p:P478
wds:Q84114038-09196C20-CEC1-41FD-B67C-901C88FA8A29
wdt:P433
1
wdt:P478
60
p:P356
wds:Q84114038-0CDF5369-BDA0-48A3-AE9F-40A89AD8FC80
wdtn:P356
n11:J.JACC.2012.03.025
wdt:P356
10.1016/J.JACC.2012.03.025